Cargando…

How patients experience thyroid eye disease

OBJECTIVE: To determine the impact of thyroid eye disease (TED) on patients in various stages of the disease. BACKGROUND: TED is a debilitating and potentially sight-threatening inflammatory autoimmune disease that is frequently misdiagnosed. Challenging quality-of-life (QoL) issues can persist long...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Terry J., Hegedüs, Laszlo, Lesser, Ira, Perros, Petros, Dorris, Kimberly, Kinrade, Michele, Troy-Ott, Patti, Wuerth, Laura, Nori, Mukund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665908/
https://www.ncbi.nlm.nih.gov/pubmed/38027128
http://dx.doi.org/10.3389/fendo.2023.1283374
_version_ 1785138930503385088
author Smith, Terry J.
Hegedüs, Laszlo
Lesser, Ira
Perros, Petros
Dorris, Kimberly
Kinrade, Michele
Troy-Ott, Patti
Wuerth, Laura
Nori, Mukund
author_facet Smith, Terry J.
Hegedüs, Laszlo
Lesser, Ira
Perros, Petros
Dorris, Kimberly
Kinrade, Michele
Troy-Ott, Patti
Wuerth, Laura
Nori, Mukund
author_sort Smith, Terry J.
collection PubMed
description OBJECTIVE: To determine the impact of thyroid eye disease (TED) on patients in various stages of the disease. BACKGROUND: TED is a debilitating and potentially sight-threatening inflammatory autoimmune disease that is frequently misdiagnosed. Challenging quality-of-life (QoL) issues can persist long after the active phase of disease has subsided. METHODS: A 62-question survey was designed as a hypothesis-generating instrument to identify key issues confronting patients ≥18 years old with physician-diagnosed TED. Questions focused primarily on physical and emotional status, and QoL experiences in the 2 months prior to the survey. Data for individual questions are presented as summary statistics. Correlations between questions were determined using χ(2) analyses. RESULTS: The 443 respondents were 18 to >80 years old; >90% female, and >80% from the United States. Time since TED diagnosis ranged from <1 year to >10 years. Participants provided >500 free-form responses describing experiences of living with TED. Physical signs/symptoms were experienced by 307/443 (69%) patients. Of those responding to the QoL questions (N = 394), 53 (13%) reported symptoms improving, 73 (19%) reported symptoms worsening, and 255 (65%) reported no change in the 2 months prior to the survey. The most bothersome signs/symptoms were dry/gritty eyes, light sensitivity, bulging eyes, and pressure or pain behind the eyes. Respondents <60 years were significantly (p < 0.0001) more likely to report symptomatic TED than older patients. Of 394 respondents, 179 (45%) reported feeling depressed and/or anxious, 174 (44%) reported concern about their appearance, and 73 (19%) avoided public situations; 192 (49%) reported declines in confidence or feelings of general well-being, and 78 (20%) reported an inability to achieve goals. Activities limited by TED included reading, driving, and socializing. The proportion of respondents experiencing these negative QoL measures was higher when patients reported experiencing >5 symptoms, had been diagnosed within the last 5 years, or were <60 years of age. CONCLUSIONS: Physical manifestations of TED impact QoL for patients through all phases of the disease. It is essential that physicians and healthcare professionals become more familiar with patient experiences such as those described here to better help patients manage their disease.
format Online
Article
Text
id pubmed-10665908
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106659082023-01-01 How patients experience thyroid eye disease Smith, Terry J. Hegedüs, Laszlo Lesser, Ira Perros, Petros Dorris, Kimberly Kinrade, Michele Troy-Ott, Patti Wuerth, Laura Nori, Mukund Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To determine the impact of thyroid eye disease (TED) on patients in various stages of the disease. BACKGROUND: TED is a debilitating and potentially sight-threatening inflammatory autoimmune disease that is frequently misdiagnosed. Challenging quality-of-life (QoL) issues can persist long after the active phase of disease has subsided. METHODS: A 62-question survey was designed as a hypothesis-generating instrument to identify key issues confronting patients ≥18 years old with physician-diagnosed TED. Questions focused primarily on physical and emotional status, and QoL experiences in the 2 months prior to the survey. Data for individual questions are presented as summary statistics. Correlations between questions were determined using χ(2) analyses. RESULTS: The 443 respondents were 18 to >80 years old; >90% female, and >80% from the United States. Time since TED diagnosis ranged from <1 year to >10 years. Participants provided >500 free-form responses describing experiences of living with TED. Physical signs/symptoms were experienced by 307/443 (69%) patients. Of those responding to the QoL questions (N = 394), 53 (13%) reported symptoms improving, 73 (19%) reported symptoms worsening, and 255 (65%) reported no change in the 2 months prior to the survey. The most bothersome signs/symptoms were dry/gritty eyes, light sensitivity, bulging eyes, and pressure or pain behind the eyes. Respondents <60 years were significantly (p < 0.0001) more likely to report symptomatic TED than older patients. Of 394 respondents, 179 (45%) reported feeling depressed and/or anxious, 174 (44%) reported concern about their appearance, and 73 (19%) avoided public situations; 192 (49%) reported declines in confidence or feelings of general well-being, and 78 (20%) reported an inability to achieve goals. Activities limited by TED included reading, driving, and socializing. The proportion of respondents experiencing these negative QoL measures was higher when patients reported experiencing >5 symptoms, had been diagnosed within the last 5 years, or were <60 years of age. CONCLUSIONS: Physical manifestations of TED impact QoL for patients through all phases of the disease. It is essential that physicians and healthcare professionals become more familiar with patient experiences such as those described here to better help patients manage their disease. Frontiers Media S.A. 2023-11-09 /pmc/articles/PMC10665908/ /pubmed/38027128 http://dx.doi.org/10.3389/fendo.2023.1283374 Text en Copyright © 2023 Smith, Hegedüs, Lesser, Perros, Dorris, Kinrade, Troy-Ott, Wuerth and Nori https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Smith, Terry J.
Hegedüs, Laszlo
Lesser, Ira
Perros, Petros
Dorris, Kimberly
Kinrade, Michele
Troy-Ott, Patti
Wuerth, Laura
Nori, Mukund
How patients experience thyroid eye disease
title How patients experience thyroid eye disease
title_full How patients experience thyroid eye disease
title_fullStr How patients experience thyroid eye disease
title_full_unstemmed How patients experience thyroid eye disease
title_short How patients experience thyroid eye disease
title_sort how patients experience thyroid eye disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665908/
https://www.ncbi.nlm.nih.gov/pubmed/38027128
http://dx.doi.org/10.3389/fendo.2023.1283374
work_keys_str_mv AT smithterryj howpatientsexperiencethyroideyedisease
AT hegeduslaszlo howpatientsexperiencethyroideyedisease
AT lesserira howpatientsexperiencethyroideyedisease
AT perrospetros howpatientsexperiencethyroideyedisease
AT dorriskimberly howpatientsexperiencethyroideyedisease
AT kinrademichele howpatientsexperiencethyroideyedisease
AT troyottpatti howpatientsexperiencethyroideyedisease
AT wuerthlaura howpatientsexperiencethyroideyedisease
AT norimukund howpatientsexperiencethyroideyedisease